Innovent Biologics, Inc.

IVBXF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$7,508$10,052$1,016$1,359
Short-Term Investments$376$868$7,248$6,581
Receivables$1,567$1,006$912$1,182
Inventory$822$968$1,429$1,347
Other Curr. Assets$0$484$0$7
Total Curr. Assets$10,273$13,428$11,507$11,551
Property Plant & Equip (Net)$5,647$4,656$4,061$3,376
Goodwill$0$0$0$0
Intangibles$1,283$28$1,198$772
Long-Term Investments$3,901$794$630-$6,164
Tax Assets$0$0$0$0
Other NC Assets$499$1,721$193$6,709
Total NC Assets$11,330$7,199$6,082$4,693
Other Assets$0$0$0$0
Total Assets$21,603$20,627$17,589$16,244
Liabilities
Payables$358$373$326$195
Short-Term Debt$414$1,220$914$387
Tax Payable$0$194$61$93
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,597$2,690$2,198$2,375
Total Curr. Liab.$4,369$4,477$3,499$3,050
LT Debt$2,417$2,400$2,314$2,110
Deferred Rev, NC$0$960$883$753
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,699$263$162$0
Total NC Liab.$4,116$3,623$3,360$2,863
Other Liabilities$0$0$0$0
Cap. Leases$14$99$125$109
Total Liabilities$8,485$8,100$6,859$5,913
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$15,906-$15,768-$14,740-$12,560
AOCI$1,301$971$764$397
Other Equity$27,723$27,324$24,706$22,494
Total Equity$13,118$12,528$10,730$10,330
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$21,603$20,627$17,589$16,244
Net Debt-$4,677-$6,432$2,212$1,138
Innovent Biologics, Inc. (IVBXF) Financial Statements & Key Stats | AlphaPilot